$VCYT
Veracyte Inc

2021 Q4 Form 10-Q Financial Statement

#000138410121000174 Filed on November 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $67.34M $60.37M $31.12M
YoY Change 94.97% 93.98% 0.48%
Cost Of Revenue $22.88M $21.64M $10.37M
YoY Change 104.49% 108.71% 13.78%
Gross Profit $44.45M $38.73M $20.75M
YoY Change 90.38% 86.64% -5.07%
Gross Profit Margin 66.02% 64.15% 66.68%
Selling, General & Admin $28.32M $42.42M $19.50M
YoY Change 12.61% 117.52% -1.07%
% of Gross Profit 63.71% 109.53% 93.98%
Research & Development $10.35M $8.006M $4.042M
YoY Change 128.37% 98.07% 10.95%
% of Gross Profit 23.27% 20.67% 19.48%
Depreciation & Amortization $6.404M $6.139M $1.990M
YoY Change 217.03% 208.49% 105.15%
% of Gross Profit 14.41% 15.85% 9.59%
Operating Expenses $52.99M $50.43M $23.54M
YoY Change 68.64% 114.18% 0.8%
Operating Profit -$8.533M -$16.68M -$4.066M
YoY Change 5.74% 310.26% 130.63%
Interest Expense $103.0K $674.0K $55.00K
YoY Change -306.0% 1125.45% -5.17%
% of Operating Profit
Other Income/Expense, Net $913.0K $1.202M -$58.00K
YoY Change 1041.25% -2172.41% -105.32%
Pretax Income -$11.32M -$15.48M -$4.124M
YoY Change 40.76% 275.34% 464.93%
Income Tax -$789.0K -$1.400M $0.00
% Of Pretax Income
Net Earnings -$10.53M -$14.13M -$4.124M
YoY Change 30.88% 242.6% 464.93%
Net Earnings / Revenue -15.64% -23.4% -13.25%
Basic Earnings Per Share -$0.20 -$0.08
Diluted Earnings Per Share -$148.1K -$0.20 -$0.08
COMMON SHARES
Basic Shares Outstanding 71.04M shares 69.74M shares 54.86M shares
Diluted Shares Outstanding 69.74M shares 54.86M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $173.2M $164.0M $345.1M
YoY Change -50.43% -52.47% 76.34%
Cash & Equivalents $173.2M $164.0M $345.1M
Short-Term Investments
Other Short-Term Assets $17.22M $15.15M $3.200M
YoY Change 438.09% 373.31% 45.45%
Inventory $11.23M $9.824M $4.456M
Prepaid Expenses
Receivables $41.46M $40.31M $17.63M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $243.1M $229.3M $370.3M
YoY Change -35.29% -38.08% 62.36%
LONG-TERM ASSETS
Property, Plant & Equipment $15.10M $30.87M $8.914M
YoY Change 67.94% 246.3% 5.02%
Goodwill $707.9M $714.3M $2.725M
YoY Change 25877.98% 26111.85% 157.81%
Intangibles $202.7M $209.5M
YoY Change 238.31%
Long-Term Investments
YoY Change
Other Assets $2.198M $1.636M $2.303M
YoY Change 57.11% -28.96% 87.54%
Total Long-Term Assets $944.7M $957.0M $83.84M
YoY Change 1059.4% 1041.57% 160.13%
TOTAL ASSETS
Total Short-Term Assets $243.1M $229.3M $370.3M
Total Long-Term Assets $944.7M $957.0M $83.84M
Total Assets $1.188B $1.186B $454.2M
YoY Change 159.83% 161.23% 74.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.36M $11.20M $1.932M
YoY Change 296.66% 479.76% -65.3%
Accrued Expenses $39.48M $29.04M $10.45M
YoY Change 237.25% 178.07% 7.02%
Deferred Revenue $4.646M $3.440M
YoY Change 1152.29%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.127M
YoY Change
Total Short-Term Liabilities $64.15M $50.04M $13.92M
YoY Change 282.28% 259.49% -17.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.075M $756.0K
YoY Change -100.0% 42.2% 18.31%
Other Long-Term Liabilities $1.407M $1.891M $16.80M
YoY Change -88.74% 41.18%
Total Long-Term Liabilities $1.407M $2.966M $756.0K
YoY Change 73.7% 292.33% 18.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.15M $50.04M $13.92M
Total Long-Term Liabilities $1.407M $2.966M $756.0K
Total Liabilities $91.31M $79.28M $31.43M
YoY Change 154.13% 152.26% 7.32%
SHAREHOLDERS EQUITY
Retained Earnings -$357.2M -$346.6M -$273.6M
YoY Change 26.83% 26.72% 14.35%
Common Stock $1.469B $1.462B $696.3M
YoY Change 108.98% 109.95% 48.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.097B $1.107B $422.7M
YoY Change
Total Liabilities & Shareholders Equity $1.188B $1.186B $454.2M
YoY Change 159.83% 161.23% 74.47%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$10.53M -$14.13M -$4.124M
YoY Change 30.88% 242.6% 464.93%
Depreciation, Depletion And Amortization $6.404M $6.139M $1.990M
YoY Change 217.03% 208.49% 105.15%
Cash From Operating Activities $8.446M -$1.393M $1.750M
YoY Change 273.72% -179.6% -212.9%
INVESTING ACTIVITIES
Capital Expenditures -$841.0K -$1.812M -$640.0K
YoY Change -5.51% 183.13% 166.67%
Acquisitions
YoY Change
Other Investing Activities $1.226M -$163.6M -$1.000M
YoY Change 16264.5%
Cash From Investing Activities $385.0K -$165.5M -$1.640M
YoY Change -143.26% 9988.84% 645.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $193.8M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 173.0K 3.215M 197.5M
YoY Change -94.08% -98.37% 4023.38%
NET CHANGE
Cash From Operating Activities 8.446M -1.393M 1.750M
Cash From Investing Activities 385.0K -165.5M -1.640M
Cash From Financing Activities 173.0K 3.215M 197.5M
Net Change In Cash 9.004M -163.6M 197.6M
YoY Change 109.88% -182.8% 6443.71%
FREE CASH FLOW
Cash From Operating Activities $8.446M -$1.393M $1.750M
Capital Expenditures -$841.0K -$1.812M -$640.0K
Free Cash Flow $9.287M $419.0K $2.390M
YoY Change 194.83% -82.47% -282.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001384101
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1399000 USD
dei Entity File Number
EntityFileNumber
001-36156
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q3 us-gaap Defined Benefit Plan Type Extensible List
DefinedBenefitPlanTypeExtensibleList
us-gaap:PensionPlansDefinedBenefitMember
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q3 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
VERACYTE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5455398
dei Entity Address Address Line1
EntityAddressAddressLine1
6000 Shoreline Court
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
(650)
dei Local Phone Number
LocalPhoneNumber
243-6300
dei Security12b Title
Security12bTitle
Common Stock, par value, $0.001 per share
dei Trading Symbol
TradingSymbol
VCYT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71043062 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164029000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
349364000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40309000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18461000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
9824000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
4657000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15146000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3197000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
229308000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
375679000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14868000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
8990000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16001000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7843000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
209521000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
59924000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
714273000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
2725000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
749000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
603000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1636000 USD
CY2021Q3 us-gaap Assets
Assets
1186356000 USD
CY2020Q4 us-gaap Assets
Assets
457163000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11201000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3116000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29044000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11705000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3440000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
371000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2646000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3465000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1589000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
241000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
50037000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16781000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1075000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
810000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
552000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
829000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6234000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5251000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7594000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14236000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9917000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1891000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2021Q3 us-gaap Liabilities
Liabilities
79276000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
35931000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71032336 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71032336 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58200526 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58200526 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
71000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
58000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1461778000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
702768000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-346629000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-281594000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8140000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1107080000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
421232000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1186356000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
457163000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60370000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31121000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
152178000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
82947000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8006000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4042000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19591000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12618000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21670000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10955000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
57628000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
39240000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20749000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8546000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
82504000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24316000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4983000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1274000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10507000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3822000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
77051000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
35187000 USD
us-gaap Costs And Expenses
CostsAndExpenses
221748000 USD
us-gaap Costs And Expenses
CostsAndExpenses
110264000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16681000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4066000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-69570000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-27317000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1202000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-58000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-762000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
452000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15479000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4124000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70332000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26865000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1350000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5297000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14129000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4124000 USD
us-gaap Net Income Loss
NetIncomeLoss
-65035000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26865000 USD
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69743733 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69743733 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54858052 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54858052 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66820654 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66820654 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51632750 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51632750 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14129000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4124000 USD
us-gaap Net Income Loss
NetIncomeLoss
-65035000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26865000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8140000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8140000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22269000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4124000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73175000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26865000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
971177000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
147089000 USD
CY2021Q3 vcyt Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
2844000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1195000 USD
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
824000 USD
CY2021Q3 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee
7359000 USD
CY2021Q3 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Non Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee
15000 USD
CY2021Q3 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Espp
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP
494000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14129000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8140000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1107080000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
421232000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
38677000 USD
vcyt Stock Issued And Sold During Period Value In Private Placement
StockIssuedAndSoldDuringPeriodValueInPrivatePlacement
593821000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
147089000 USD
vcyt Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
8280000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2353000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
8307000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee
14687000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Non Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee
45000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Espp
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP
1055000 USD
us-gaap Net Income Loss
NetIncomeLoss
-65035000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8140000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1107080000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
226147000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
13169000 USD
CY2020Q3 vcyt Stock Issued And Sold During Period Value In Private Placement
StockIssuedAndSoldDuringPeriodValueInPrivatePlacement
193831000 USD
CY2020Q3 vcyt Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
3329000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
935000 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
483000 USD
CY2020Q3 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee
3032000 USD
CY2020Q3 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Non Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee
15000 USD
CY2020Q3 vcyt Adjustments To Additional Paid In Capital Share Based Compensation Espp
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP
43000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4124000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4124000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
422725000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
239455000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
13169000 USD
vcyt Stock Issued And Sold During Period Value In Private Placement
StockIssuedAndSoldDuringPeriodValueInPrivatePlacement
193831000 USD
vcyt Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
8074000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2037000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3161000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee
8591000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Non Employee
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee
35000 USD
vcyt Adjustments To Additional Paid In Capital Share Based Compensation Espp
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP
728000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26865000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-26865000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
422725000 USD
us-gaap Net Income Loss
NetIncomeLoss
-65035000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26865000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13189000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5919000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
15787000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9354000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5297000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
vcyt Debt Instrument End Of Term Payment Interest Amount And Prepayment Penalty
DebtInstrumentEndOfTermPaymentInterestAmountAndPrepaymentPenalty
161000 USD
vcyt Debt Instrument End Of Term Payment Interest Amount And Prepayment Penalty
DebtInstrumentEndOfTermPaymentInterestAmountAndPrepaymentPenalty
162000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
1088000 USD
vcyt Noncash Lease Expense
NoncashLeaseExpense
1566000 USD
vcyt Noncash Lease Expense
NoncashLeaseExpense
714000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
303000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
332000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1601000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
17000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6285000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1742000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1262000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1905000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
923000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-353000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-134000 USD
vcyt Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1710000 USD
vcyt Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1040000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3872000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-534000 USD
vcyt Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
3329000 USD
vcyt Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
-3300000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40067000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11972000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
574411000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
163645000 USD
us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
0 USD
us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
3000000 USD
us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
0 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
1000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4535000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1949000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-739591000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2949000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
593821000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
193831000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
100000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8307000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3161000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10633000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10114000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
596147000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
200684000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-183511000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
185763000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1678000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-185189000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
185763000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
164778000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
349967000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159920000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
345683000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
31000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
355000 USD
us-gaap Interest Paid Net
InterestPaidNet
9000 USD
us-gaap Interest Paid Net
InterestPaidNet
3000 USD
us-gaap Stock Issued1
StockIssued1
147089000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164029000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
349364000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
749000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
603000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
164778000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
349967000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Items subject to such estimates include: revenue recognition; write-down of supplies; the useful lives of property and equipment; the recoverability of long-lived assets; the incremental borrowing rate for leases; accounting for acquisitions; the estimation of the fair value of intangible assets and contingent consideration; stock options; income tax uncertainties, including a valuation allowance for deferred tax assets; an allowance for credit losses and contingencies. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</span></div>
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
8547297 shares
CY2021Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
593800000 USD
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
38700000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
749000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
603000 USD
CY2021Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
1100000 USD
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4929512 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5399174 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4845503 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5641543 shares
CY2020Q4 us-gaap Goodwill
Goodwill
2725000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-6317000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
714273000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
223197000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20976000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
202221000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
70420000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10496000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
59924000 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y10M24D
CY2021Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
7300000 USD
CY2021Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
7300000 USD
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
230497000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20976000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
209521000 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
70420000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10496000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
59924000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5000000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10500000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3800000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5542000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
22165000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
22165000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
22125000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
21679000 USD
CY2021Q3 vcyt Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
108545000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
202221000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22628000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9201000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6416000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2504000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29044000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11705000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1042000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4226000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4296000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4310000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4380000 USD
CY2021Q3 vcyt Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
2487000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20741000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3040000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
17701000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3465000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14236000 USD
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
982000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
472000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
2460000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1417000 USD
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1011000 USD
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
587000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2518000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1744000 USD
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
700000 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
700000 USD
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10891288 shares
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9500287 shares
CY2021Q3 vcyt Other Nonoperating Income Expense Foreign Tax Credit
OtherNonoperatingIncomeExpenseForeignTaxCredit
419000 USD
CY2020Q3 vcyt Other Nonoperating Income Expense Foreign Tax Credit
OtherNonoperatingIncomeExpenseForeignTaxCredit
0 USD
vcyt Other Nonoperating Income Expense Foreign Tax Credit
OtherNonoperatingIncomeExpenseForeignTaxCredit
419000 USD
vcyt Other Nonoperating Income Expense Foreign Tax Credit
OtherNonoperatingIncomeExpenseForeignTaxCredit
0 USD
CY2021Q3 vcyt Other Nonoperating Income Expense Interest Income
OtherNonoperatingIncomeExpenseInterestIncome
27000 USD
CY2020Q3 vcyt Other Nonoperating Income Expense Interest Income
OtherNonoperatingIncomeExpenseInterestIncome
3000 USD
vcyt Other Nonoperating Income Expense Interest Income
OtherNonoperatingIncomeExpenseInterestIncome
46000 USD
vcyt Other Nonoperating Income Expense Interest Income
OtherNonoperatingIncomeExpenseInterestIncome
21000 USD
CY2021Q3 vcyt Other Nonoperating Income Expense Interest Expense
OtherNonoperatingIncomeExpenseInterestExpense
61000 USD
CY2020Q3 vcyt Other Nonoperating Income Expense Interest Expense
OtherNonoperatingIncomeExpenseInterestExpense
55000 USD
vcyt Other Nonoperating Income Expense Interest Expense
OtherNonoperatingIncomeExpenseInterestExpense
177000 USD
vcyt Other Nonoperating Income Expense Interest Expense
OtherNonoperatingIncomeExpenseInterestExpense
175000 USD
CY2021Q3 vcyt Other Nonoperating Income Expense Foreign Currency Translation Gain Loss
OtherNonoperatingIncomeExpenseForeignCurrencyTranslationGainLoss
708000 USD
CY2020Q3 vcyt Other Nonoperating Income Expense Foreign Currency Translation Gain Loss
OtherNonoperatingIncomeExpenseForeignCurrencyTranslationGainLoss
-8000 USD
vcyt Other Nonoperating Income Expense Foreign Currency Translation Gain Loss
OtherNonoperatingIncomeExpenseForeignCurrencyTranslationGainLoss
-1159000 USD
vcyt Other Nonoperating Income Expense Foreign Currency Translation Gain Loss
OtherNonoperatingIncomeExpenseForeignCurrencyTranslationGainLoss
17000 USD
CY2021Q3 vcyt Other Nonoperating Income Expense Other
OtherNonoperatingIncomeExpenseOther
109000 USD
CY2020Q3 vcyt Other Nonoperating Income Expense Other
OtherNonoperatingIncomeExpenseOther
2000 USD
vcyt Other Nonoperating Income Expense Other
OtherNonoperatingIncomeExpenseOther
109000 USD
vcyt Other Nonoperating Income Expense Other
OtherNonoperatingIncomeExpenseOther
589000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1202000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-58000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-762000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
452000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5300000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD

Files In Submission

Name View Source Status
0001384101-21-000174-index-headers.html Edgar Link pending
0001384101-21-000174-index.html Edgar Link pending
0001384101-21-000174.txt Edgar Link pending
0001384101-21-000174-xbrl.zip Edgar Link pending
ex101-chambersrebeccaoffer.htm Edgar Link pending
ex102-chambersrebeccachang.htm Edgar Link pending
exhibit31109-30x2021.htm Edgar Link pending
exhibit31209-30x2021.htm Edgar Link pending
exhibit32109-30x2021.htm Edgar Link pending
exhibit32209-30x2021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vcyt-20210930.htm Edgar Link pending
vcyt-20210930.xsd Edgar Link pending
vcyt-20210930_cal.xml Edgar Link unprocessable
vcyt-20210930_def.xml Edgar Link unprocessable
vcyt-20210930_htm.xml Edgar Link completed
vcyt-20210930_lab.xml Edgar Link unprocessable
vcyt-20210930_pre.xml Edgar Link unprocessable